Applied Clinical Trials:
Having trouble viewing this e-mail? Click here.

 
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.

Oncology Trials Update


Applied Clinical Trials

 
 
 
 
Most Popular: Cardiac Safety: Cost to Trials // Perceptive Informatics Strengthens Cardiac Capabilities // April Issue
_____
  FindPharma  
  Search  
ERT on Acquisition
Cetero’s TQT Milestone
Clinilabs, NewCardio Agreement
Cardiac Summit
FDA and Avandia
Key Topic Updates

The 1st DIA Cardiac Safety Workshop in Japan
May 25-May 26,
Tokyo, Japan


IIR Central Labs East
September 20-22, 2010 , Boston, MA


DIA 4th European Cardiac Safety Conference
October 25-October 26 , Nice, France


LCGC Europe - FacebookJoin Our Facebook Discussion on Paying the Phase I Volunteer


LCGC Europe - News Update
Partnerships for Cardiac Safety
Public/Private Partnerships To Help Determine Clinical Biomarker Utility
  Coming in June at appliedclincialtrialsonline.com: Peer-Reviewed Article
Integrated Cardiovascular Safety; Expanding our Assessment Horizons for Prospectively Excluding Unacceptable Cardiovascular Risks
J. Rick Turner, PhD, Senior Director, Cardiovascular Safety, Quintiles

Sponsors—Nominate Your Innovative Therapy to the Prix Galien Committee Today!
Nominations due May 31, 2010

Contact Us
Click here to contact Lisa Henderson, Editor in Chief.

Click here to learn about direct mail opportunities.

Click here to learn about advertising opportunities.

Click here to learn about reprints of Applied Clinical Trials.

May 11, 2010
ERT To Acquire CareFusion’s Research Services Division
ERT’s acquisition will enhance not only its cardiac safety services, but offers synergies in its ePRO and consulting lines of business. More...
Cetero Research Completes 50th TQT Trial
Cetero Research, an early-stage CRO, announced it completed its 50th definitive TQT trial, and has successfully recruited more than 5,300 cardiac safety trial participants. More...
Clinilabs Signs MSA with NewCardio
Clinilabs, a CRO based in New York, has signed a Master Services Agreement with cardiac diagnostic technology provider NewCardio. More...
CBI’s Cardiac Safety Summit
The Center for Business Intelligence tackled Cardiac Safety approaches in drug evaluation head on this past January. Applied Clinical Trials relates the highlights of the event. More...
Avandia’s Heart Safety Issues In the News Again
This blog from our sister publication Pharmaceutical Executive highlights the FDA’s concern of the heart attack risk issues associated with GSK’s diabetes drug. More...
Key Topic Updates
Centralized Cardiac Lab
Following its release of Centralized Cardiac Safety 2.0, Applied Clinical Trials spoke to John Blakely, Executive Vice President, Sales and Marketing for ERT about the new platform.
Safety and Regulatory
This podcast from Dr. David Orloff from CRO Medpace addresses cardiovascular safety issues in regard to diabetes and obesity drugs.
Lawrence Satin, MD, FACC, Chief Medical Officer and Founder of CardioCore, updates Applied Clinical Trials on the importance of cardiac safety testing early in the drug development process.
Resources
The Telemetric and Holter ECG Warehouse
Framingham Heart Study
FDA Guidance for Industry – E14 Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Non-Antiarrhythmic Drugs
Community
Biomedical Systems' Cardiology Division Expands Sales Team
ERT Appoints New Associate Director of Business Development
NewCardio Elects Michael E. Hanson to Board of Directors

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, simply call (toll free) 866-529-2922 at any time, or
fax us at 218-740-6417. Outside the U.S., please phone 218-740-6395. Contact us by mail at Advanstar
Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.